TheraRadar

Pharma Intelligence, Simplified

Landscape Sleep

Insomnia

184 clinical trials

68 active
/
184 total (since 2015)
7
Phase 1 Active
20 total
26
Phase 2 Active
69 total
15
Phase 3 Active
44 total
23
Phase 4 Active
63 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. 5 4 0
Vanda Pharmaceuticals 4 2 0
Idorsia Pharmaceuticals Ltd. 1 7 0
Sequential Medicine Ltd 1 2 1
Merck 1 0 0
Apsen Farmaceutica S.A. 1 0 0
Proactive Life Inc 1 0 0
RDC Clinical Pty Ltd 1 0 0
Reconnect Labs 1 0 0
Avecho Biotechnology 1 0 0
Nyree Penn 1 0 0
Afasci Inc 1 0 0
Nanjing Chia-tai Tianqing Pharmaceutical 1 0 0
ProofPilot 1 0 0
Taisho Pharmaceutical Co., Ltd. 0 4 0
NCT06655883 RECRUITING
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Merck Sharp & Dohme LLC n=300
NCT06476392 ACTIVE NOT RECRUITING
Melatonin fOr CHronic bAck Pain (The MOCHA Trial)
Odense University Hospital n=220
NCT03668041 ACTIVE NOT RECRUITING
National Adaptive Trial for PTSD Related Insomnia
VA Office of Research and Development n=673
NCT04652882 RECRUITING
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Vanda Pharmaceuticals n=70
NCT06619912 RECRUITING
Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients
Xijing Hospital n=686
NCT06975514 RECRUITING
Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. n=60
NCT05840822 RECRUITING
Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia
Avecho Biotechnology n=519
NCT06953869 RECRUITING
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Vanda Pharmaceuticals n=420
NCT06062953 RECRUITING
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
Lone Baandrup n=255
NCT06859190 RECRUITING
Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
Qinghai Red Cross Hospital n=60
NCT04050176 ACTIVE NOT RECRUITING
Use of Blinded Tapering for Hypnotic Discontinuation
National Jewish Health n=260
NCT06701396 RECRUITING
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
Vanda Pharmaceuticals n=60
NCT06512363 NOT YET RECRUITING
A Study of Ramelteon in Chinese Patients With Chronic Insomnia
Nanjing Chia-tai Tianqing Pharmaceutical n=280
NCT05525637 RECRUITING
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. n=1,041
NCT05361707 RECRUITING
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
Vanda Pharmaceuticals n=100
NCT07028697 COMPLETED
A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder
Nxera Pharma Korea Co., Ltd. n=164
NCT04451668 COMPLETED
An Open Label Study of FT218 in Subjects With Narcolepsy
Avadel n=184
NCT04759703 TERMINATED
Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD
Massachusetts General Hospital n=75
NCT05461352 COMPLETED
Long-Term Study of TS-142 in Patients with Insomnia
Taisho Pharmaceutical Co., Ltd. n=401
NCT05453136 COMPLETED
Phase III Study of TS-142 in Patients with Insomnia
Taisho Pharmaceutical Co., Ltd. n=1,155
NCT06756971 WITHDRAWN
DISE in Pediatric Sleep Disordered Breathing
University of Iowa
NCT02783729 COMPLETED
Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)
Eisai Inc. n=1,006
NCT06010693 COMPLETED
A Study of Daridorexant in Chinese Patients With Insomnia Disorder
Jiangsu Simcere Pharmaceutical Co., Ltd. n=206
NCT03682185 COMPLETED
The Healthy Patterns Sleep Study
University of Pennsylvania n=421
NCT03338764 WITHDRAWN
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
Sequential Medicine Ltd
NCT05015803 COMPLETED
Enhanced CBTi for Older Adult Sleep and Cognition
Penn State University n=60
NCT03534284 COMPLETED
Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis
University of Washington n=126
NCT03771664 TERMINATED
A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia
Biogen n=87
NCT05346588 COMPLETED
THRIVE Feasibility Trial
Washington University School of Medicine n=300
NCT03373201 COMPLETED
Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
Vanda Pharmaceuticals n=320
NCT03575104 COMPLETED
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Idorsia Pharmaceuticals Ltd. n=924
NCT03545191 COMPLETED
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder
Idorsia Pharmaceuticals Ltd. n=930
NCT03679884 COMPLETED
Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Idorsia Pharmaceuticals Ltd. n=804
NCT02333149 WITHDRAWN
Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population
University of Alberta
NCT02987985 COMPLETED
Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy
University of Saskatchewan n=50
NCT03478306 COMPLETED
Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm
Glostrup University Hospital, Copenhagen n=31
NCT04009577 COMPLETED
A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia
Eisai Inc. n=53
NCT03075241 COMPLETED
Z-Drugs for Sleep Disorders in Alzheimer's Disease
Brasilia University Hospital n=62
NCT02952820 COMPLETED
Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)
Eisai Inc. n=971
NCT03331042 COMPLETED
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
Sequential Medicine Ltd n=85
NCT02757066 COMPLETED
Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders
Nobelpharma n=196
NCT02757079 COMPLETED
Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders
Nobelpharma n=99
NCT02108353 COMPLETED
Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers
Universitätsklinikum Hamburg-Eppendorf n=46
NCT02232256 WITHDRAWN
The Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain
9305-9954 Quebec Inc